HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.02.078v1 48/8/1538    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (23) Citing Articles via Google Scholar Google Scholar Articles by Boos, C. J. Articles by Blann, A. D. Search for Related Content PubMed PubMed Citation Articles by Boos, C. J. Articles by Blann, A. D.

CARDIOVASCULAR GENOMIC MEDICINE

Circulating Endothelial Cells in Cardiovascular Disease

Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

Manuscript received December 13, 2005; revised manuscript received February 8, 2006, accepted February 14, 2006.

^_* Reprint requests and correspondence: Dr. Andrew D. Blann, University Department of Medicine City Hospital, Haemostasis, Thrombosis, and Vascular Biology, Dudley Road, Birmingham B18 7QH, United Kingdom (Email: a.blann{at}bham.ac.uk).

Quantification of circulating endothelial cells (CECs) in peripheral blood is developing as a novel and reproducible method of assessing endothelial damage/dysfunction. The CECs are thought to be mature cells that have detached from the intimal monolayer in response to endothelial injury and are a different cell population to endothelial progenitor cells (EPCs). The EPCs are nonleukocytes derived from the bone marrow that are believed to have proliferative potential and may be important in vascular regeneration. Currently accepted methods of CEC quantification include the use of immunomagnetic bead separation (with cell counting under fluorescence microscopy) and flow cytometry. Several recent studies have shown increased numbers of CECs in cardiovascular disease and its risk factors, such as unstable angina, acute myocardial infarction, stroke, diabetes mellitus, and critical limb ischemia, but no change in stable intermittent claudication, essential hypertension, or atrial fibrillation. Furthermore, CEC quantification at 48 h after acute myocardial infarction has been shown to be an accurate predictor of major adverse coronary events and death at both 1 month and 1 year. This article presents an overview of the pathophysiology of CECs in the setting of cardiovascular disease and a brief comparison with EPCs.

Abbreviations and Acronyms   AF = atrial fibrillation   CAD = coronary artery disease   CEC = circulating endothelial cell   CVD = cardiovascular disease   EPC = endothelial progenitor cell   FMD = flow-mediated dilatation   MI = myocardial infarction   PVD = peripheral vascular disease   VEGFR = vascular endothelial growth factor receptor   vWf = von Willebrand factor

This article has been cited by other articles:

				M. Pirro, F. Bagaglia, L. Paoletti, R. Razzi, and M. R. Mannarino Review: Hypercholesterolemia-associated endothelial progenitor cell dysfunction Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 329 - 339. [Abstract] [PDF]

				E. Mannarino and M. Pirro Endothelial Injury and Repair: A Novel Theory for Atherosclerosis Angiology, August 1, 2008; 59(2_suppl): 69S - 72S. [Abstract] [PDF]

				A. Surdacki, E. Marewicz, E. Wieteska, G. Szastak, T. Rakowski, E. Wieczorek-Surdacka, D. Dudek, J. Pryjma, and J. S. Dubiel Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2265 - 2273. [Abstract] [Full Text] [PDF]

				G. Yao, Z.-H. Liu, C. Zheng, X. Zhang, H. Chen, C. Zeng, and L.-S. Li Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis Rheumatology, April 1, 2008; 47(4): 432 - 436. [Abstract] [Full Text] [PDF]

				B. Pitt N-terminal pro-B-type natriuretic peptide concentrations >=100 ng/l increased risk of all-cause mortality Evid. Based Med., February 1, 2008; 13(1): 26 - 26. [Full Text] [PDF]

				C. J. Boos, B. Balakrishnan, S. Jessani, A. D. Blann, and G. Y. H. Lip Effects of Percutaneous Coronary Intervention on Peripheral Venous Blood Circulating Endothelial Cells and Plasma Indices of Endothelial Damage/Dysfunction Chest, December 1, 2007; 132(6): 1920 - 1926. [Abstract] [Full Text] [PDF]

				C. J. Boos, D. A. Lane, M. Karpha, D. G. Beevers, R. Haynes, and G. Y. H. Lip Circulating Endothelial Cells, Arterial Stiffness, and Cardiovascular Risk Stratification in Hypertension Chest, November 1, 2007; 132(5): 1540 - 1547. [Abstract] [Full Text] [PDF]

				P. K. Y. Goon, T. Watson, and G. Y. H. Lip Circulating Endothelial Cells in Obstructive Sleep Apnea: An Important Methodological Lesson Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1346 - 1346. [Full Text] [PDF]

				C. J. Boos, S. K. Soor, D. Kang, and G. Y.H. Lip Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes Eur. Heart J., May 1, 2007; 28(9): 1092 - 1101. [Abstract] [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al. Highlights of the Year in JACC 2006 J. Am. Coll. Cardiol., January 30, 2007; 49(4): 509 - 527. [Full Text] [PDF]